Astramorph (morphine Iv)

Clinical Medications Worksheets Generic Name morphine

Trade Name Astramorph

Peak 20 min

Onset rapid

Classification Opioid analgesic Duration 4-5 hrs

Why is your patient getting this medication Pain

Mechanism of action and indications (Why med ordered) Binds to opiate receptors in the CNS. Alters the perception of and response to painful stimuli while producing generalized CNS depression

Dose 2mg-4mg

Route IV

Time/frequency Q 3 hrs

Normal dosage range Usual starting dose for moderate to severe pain in opioid-naive patients--4-10 mg q 3-4 hr. Rate: Administer 2.5-15 mg over 4-5 min. Rapid administration may lead to increased respiratory depression, hypotension, and circulatory collapse For IV meds, compatibility with IV drips and/or solutions Solution is colorless; do not administer discolored solution. Dilute with at least 5 ml of sterile water or 0.9% NaCl for injection to a concentration of 0.5-5 mg/ml Y-Site Incompatibility: amphotericin B cholesteryl sulfate, azithromycin, cefepime, doxorubicin liposome, minocycline, phenytoin, sargramostim Nursing Implications (what to focus on) Contraindications/warnings/interactions Hypersensitivity, Some products contain tartrazine, bisulfites, or alcohol and should be avoided in patients with known hypersensitivity Common side effects confusion, sedation, RESPIRATORY DEPRESSION, hypotension, constipation Lab value alterations caused by medicine May ↑ plasma amylase and lipase levels

Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) Detrol: Coadministration of narcotic analgesics with Be sure to teach the patient the following about this medication anticholinergic agents may have additive central nervous Instruct patient how and when to ask for pain medication. May cause system (CNS) and gastrointestinal (GI) system effects, and drowsiness or dizziness. Caution patient to call for assistance when increase the risk of severe constipation or paralytic ileus and ambulating or smoking and to avoid driving or other activities CNS depression. requiring alertness until response to medication is known. Advise Baclofen: Central nervous system- and/or respiratorypatient to change positions slowly to minimize orthostatic hypotension. depressant effects may be additively or synergistically Caution patient to avoid concurrent use of alcohol or other CNS increased in patients taking multiple drugs that cause these depressants with this medication. Encourage patients who are effects, especially in elderly or debilitated patients. immobilized or on prolonged bedrest to turn, cough, and breathe Norvasc: The concomitant administration of agents with deeply every 2 hr to prevent atelectasis. hypotensive effects and psychotherapeutic agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics), narcotic analgesics, alcohol, or muscle relaxants may additively increase hypotensive and/or central nervous system depressant effects. Nursing Process- Assessment Assessment Evaluation (Pre-administration assessment) Why would you hold or not give this med? Check after giving Assess type, location, and intensity of pain prior to If respiratory rate is <10/min, assess level of Decrease in severity of pain and 20 min (peak) following IV administration. sedation. Toxicity (administer Narcan) without a significant alteration in Assess level of consciousness, blood pressure, level of consciousness or pulse, and respirations before and periodically respiratory status during administration. Assess bowel function routinely.